1. A multi‐institutional comparison of mitoxantrone, etoposide, and cytarabine vs high‐dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia. Issue 8 (8th May 2020) Authors: Christian, Sonia; Arain, Saad; Patel, Pritesh; Khan, Irum; Calip, Gregory S.; Agrawal, Vaibhav; Sweiss, Karen; Griffin, Shawn; Cahill, Kirk; Konig, Heiko; Esen, Aysenur; Shergill, Ardaman; Odenike, Olatoyosi; Stock, Wendy; Quigley, John G. Journal: American journal of hematology Issue: Volume 95:Issue 8(2020:Aug.) Page Start: 937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel drug interaction between busulfan and blinatumomab. (January 2019) Authors: Sweiss, Karen; Quigley, John G; Oh, Annie; Lee, Jonathan; Ye, Rosa; Rondelli, Damiano; Patel, Pritesh Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 1(2019) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Issue 7 (3rd July 2018) Authors: Patel, Pritesh; Oh, Annie L.; Koshy, Matthew; Sweiss, Karen; Saraf, Santosh L.; Quigley, John G.; Khan, Irum; Mahmud, Nadim; Hacker, Eileen; Ozer, Howard; Peace, David J.; Weichselbaum, Ralph R.; Aydogan, Bulent; Rondelli, Damiano Journal: Leukemia & lymphoma Issue: Volume 59:Issue 7(2018) Page Start: 1666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant. (March 2018) Authors: Sweiss, Karen; Anderson, Jennifer; Wirth, Scott; Oh, Annie; Quigley, John; Khan, Irum; Saraf, Santosh; Mactal-Haaf, Christina; Rondelli, Damiano; Patel, Pritesh Journal: Bone marrow transplantation Issue: Volume 53:Number 3(2018) Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. (21st July 2020) Authors: Han, Jin; Holden, Christopher C.; Ahluwalia, Aneet Y.; Molokie, Robert E.; Gowhari, Michel; Sweiss, Karen; Patel, Pritesh R.; Gordeuk, Victor R.; Rondelli, Damiano; Saraf, Santosh L. Journal: British journal of haematology Issue: Volume 191:Number 3(2020) Page Start: e70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant. Issue 11 (1st May 2020) Authors: Sweiss, Karen; Vemu, Bhaskar; Hofmeister, Craig C.; Wenzler, Eric; Calip, Gregory Sampang; Galvin, John P.; Mahmud, Nadim; Rondelli, Damiano; Johnson, Jeremy James; Patel, Pritesh Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 11(2020) Page Start: 2165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6‐Year Propensity Score–Matched Cohort Study. Issue 1 (4th January 2019) Authors: Zhou, Jifang; Han, Jin; Nutescu, Edith A.; Patel, Pritesh R.; Sweiss, Karen; Calip, Gregory S. Journal: Pharmacotherapy Issue: Volume 39:Issue 1(2019) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician–pharmacist clinic. (April 2020) Authors: Sweiss, Karen; Calip, Gregory S; Wirth, Scott; Rondelli, Damiano; Patel, Pritesh Journal: Journal of oncology pharmacy practice Issue: Volume 26:Number 3(2020) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan. (April 2021) Authors: Sweiss, Karen; Calip, Gregory Sampang; Holden, Jaime; Lewkowski, Paulina; Mialik, Iryna; Johnson, Jeremy; Galvin, John P; Rondelli, Damiano; Patel, Pritesh Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 3(2021) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience. Issue 4 (28th May 2021) Authors: Uzoka, Chukwuemeka; Liu, Li C.; Park, Youngmin; Lin, Yuankai; Patel, Pritesh; Campbell‐Lee, Sally; Sweiss, Karen; Wang, Xinhe; Tepak, Elena; Peace, David; Saraf, Santosh; Rondelli, Damiano; Mahmud, Nadim Journal: Journal of clinical apheresis Issue: Volume 36:Issue 4(2021) Page Start: 634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗